The bill establishes a Minnesota Prescription Drug Purchasing Program, which will be administered by the commissioner of human services. This program aims to provide prescription drugs to medical assistance and MinnesotaCare enrollees at the lowest possible cost. The commissioner is tasked with various responsibilities, including maintaining a list of effective prescription drugs, negotiating prices with manufacturers, and managing pharmacy claims. The program will also require the commissioner to set terms for pharmacy participation and seek necessary federal approvals for implementation, which is set to begin on January 1, 2026, or upon federal approval.

Additionally, the bill mandates the development of recommendations for expanding the program to include enrollees from health plan companies that contract with the commissioner. This expansion will involve outlining the process for contracting with these companies to administer prescription drug benefits and manage a drug formulary. A report detailing these recommendations is required to be presented to relevant legislative committees by December 15, 2026.